FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Chris Van Geet

Research Profile

Anatomy

Chemicals & Drugs

Disorders

Physiology

Living Beings

Co-author Network

Publications

TOP 3
Christophe Goubau; Chris Van Geet; Gunnar M Buyse; Michela Di Michele; Kathleen Freson
Regulated granule trafficking in platelets and neurons: a common molecular machinery.
Sophie Louwette; Luc Régal; Chantal Thys; Chris Van Geet; Gwenny Vandeweeghde; Christine Wittevrongel; Rita De Vos; Elisa Decuyper; Jaak Jaeken; Peter Leemans; Kathleen Freson
NPC1 defect results in abnormal platelet formation and function: studies in Niemann-Pick disease type C1 patients and zebrafish.
Christophe Goubau; Jaak Jaeken; Elena N Levtchenko; Geert A Martens; Chantal Thys; Chris Van Geet; Gunnar M Buyse; Rita De Vos; Michela Di Michele; Erik Gerlo; Nathalie Goemans; Kathleen Freson
Homozygosity for aquaporin 7 G264V in three unrelated children with hyperglyceroluria and a mild platelet secretion defect.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Chris Van Geet (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Christophe Goubau; Chris Van Geet; Gunnar M Buyse; Michela Di Michele; Kathleen Freson
Regulated granule trafficking in platelets and neurons: a common molecular machinery.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2013;17(2):117-25.
2013: Sophie Louwette; Luc Régal; Chantal Thys; Chris Van Geet; Gwenny Vandeweeghde; Christine Wittevrongel; Rita De Vos; Elisa Decuyper; Jaak Jaeken; Peter Leemans; Kathleen Freson
NPC1 defect results in abnormal platelet formation and function: studies in Niemann-Pick disease type C1 patients and zebrafish.
Human molecular genetics 2013;22(1):61-73.
2013: Christophe Goubau; Jaak Jaeken; Elena N Levtchenko; Geert A Martens; Chantal Thys; Chris Van Geet; Gunnar M Buyse; Rita De Vos; Michela Di Michele; Erik Gerlo; Nathalie Goemans; Kathleen Freson
Homozygosity for aquaporin 7 G264V in three unrelated children with hyperglyceroluria and a mild platelet secretion defect.
Genetics in medicine : official journal of the American College of Medical Genetics 2013;15(1):55-63.
2012: Marie-France Phoba; Chris Van Geet; Raymond Vanhoof; Jan Verhaegen; Pantaléon Lewo di Mputu; Octavie Lunguya; Daniel Vita Mayimon; Jean-Jacques Muyembe; Sophie Bertrand; Jan Jacobs
Multidrug-resistant Salmonella enterica, Democratic Republic of the Congo.
Emerging infectious diseases 2012;18(10):1692-4.
2012: Michela Di Michele; Chris Van Geet; Kathleen Freson
Recent advances in platelet proteomics.
Expert review of proteomics 2012;9(4):451-66.
2012: Benedetta Izzi; Chris Van Geet; Kathleen Freson
Recent advances in GNAS epigenetic research of pseudohypoparathyroidism.
Current molecular medicine 2012;12(5):566-73.
2012: Sophie Louwette; Juriaan Metz; Chantal Thys; Chris Van Geet; Christine Wittevrongel; Jef Arnout; zeger debyser; Rik Gijsbers; Valery Labarque; Kathleen Freson
Regulator of G-protein signaling 18 controls megakaryopoiesis and the cilia-mediated vertebrate mechanosensory system.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2012;26(5):2125-36.
2012: Benedetta Izzi; Chantal Thys; Chris Van Geet; Christine Wittevrongel; Francis de Zegher; Jurgen del Favero; I Francois; Dirk Goossens; Kathleen Freson
No evidence for GNAS copy number variants in patients with features of Albright's hereditary osteodystrophy and abnormal platelet Gs activity.
Journal of human genetics 2012;57(4):277-9.
2012: Kathleen Freson; Benedetta Izzi; Chris Van Geet
From genetics to epigenetics in platelet research.
Thrombosis research 2012;129(3):325-9.
2012: Kathleen Freson; Chris Van Geet
Novel targets for platelet inhibition.
Handbook of experimental pharmacology 2012;(210):369-94.
2012: M Di Michele; Chris Van Geet; Kathleen Freson
Proteomics to unravel platelet-related diseases and identify novel anti-platelet drugs.
Current medicinal chemistry 2012;19(27):4662-70.
2012: Benedetta Izzi; Valery Labarque; Diether Lambrechts; Eric Legius; Chantal Thys; Annick Van den Bruel; Chris Van Geet; Christine Wittevrongel; Francis de Zegher; Koen Devriendt; Marc D'Hooghe; I Francois; Kathleen Freson
Methylation defect in imprinted genes detected in patients with an Albright's hereditary osteodystrophy like phenotype and platelet Gs hypofunction.
PloS one 2012;7(6):e38579.
2011: Michela Di Michele; Chantal Thys; Etienne Waelkens; Lut Overbergh; Wannes D'Hertog; Chantal Mathieu; Rita De Vos; Kathelijne Peerlinck; Chris Van Geet; Kathleen Freson
An integrated proteomics and genomics analysis to unravel a heterogeneous platelet secretion defect.
Journal of proteomics 2011;74(6):902-13.
2010: Benedetta Izzi; Brigitte Decallonne; Koen Devriendt; Roger Bouillon; Dirk Vanderschueren; Elena Levtchenko; Francis de Zegher; Annick Van den Bruel; Diether Lambrechts; Chris Van Geet; Kathleen Freson
A new approach to imprinting mutation detection in GNAS by Sequenom EpiTYPER system.
Clinica chimica acta; international journal of clinical chemistry 2010;411(23-24):2033-9.
2010: Karen Peeters; Serena Loyen; Soetkin Van Kerckhoven; Katinka Stoffels; Marc F Hoylaerts; Chris Van Geet; Kathleen Freson
Thrombopoietic effect of VPAC1 inhibition during megakaryopoiesis.
British journal of haematology 2010;151(1):54-61.
2010: Dries Castermans; Karolien Volders; An Crepel; Liesbeth Backx; Rita De Vos; Kathleen Freson; Sandra Meulemans; Joris R Vermeesch; Connie T R M Schrander-Stumpel; Peter De Rijk; Jurgen Del-Favero; Chris Van Geet; Wim J M Van De Ven; Jean G Steyaert; Koen Devriendt; John W M Creemers
SCAMP5, NBEA and AMISYN: three candidate genes for autism involved in secretion of large dense-core vesicles.
Human molecular genetics 2010;19(7):1368-78.
2010: Liesbeth de Waele; Kathleen Freson; Sophie Louwette; Chantal Thys; Christine Wittevrongel; Rita De Vos; Anne Debeer; Chris Van Geet
Severe gastrointestinal bleeding and thrombocytopenia in a child with an anti-GATA1 autoantibody.
Pediatric research 2010;67(3):314-9.
2010: L Noé; Kristel Peeters; Benedetta Izzi; Chris Van Geet; Kathleen Freson
Regulators of platelet cAMP levels: clinical and therapeutic implications.
Current medicinal chemistry 2010;17(26):2897-905.
2009: Hendrik B Feys; Inge Pareyn; Renee Vancraenenbroeck; Marc De Maeyer; Hans Deckmyn; Chris Van Geet; Karen Vanhoorelbeke
Mutation of the H-bond acceptor S119 in the ADAMTS13 metalloprotease domain reduces secretion and substrate turnover in a patient with congenital thrombotic thrombocytopenic purpura.
Blood 2009;114(21):4749-52.
2008: Kathleen Freson; Benedetta Izzi; Veerle Labarque; Maria van Helvoirt; Chantal Thys; Christine Wittevrongel; Marie Bex; Roger Bouillon; Nathalie Godefroid; Willem Proesmans; Francis de Zegher; Jaak Jaeken; Chris Van Geet
GNAS defects identified by stimulatory G protein alpha-subunit signalling studies in platelets.
The Journal of clinical endocrinology and metabolism 2008;93(12):4851-9.
2008: Kathleen Freson; Benedetta Izzi; Jaak Jaeken; Maria van Helvoirt; Chantal Thys; Christine Wittevrongel; Francis de Zegher; Chris Van Geet
Compound heterozygous mutations in the GNAS gene of a boy with morbid obesity, thyroid-stimulating hormone resistance, pseudohypoparathyroidism, and a prothrombotic state.
The Journal of clinical endocrinology and metabolism 2008;93(12):4844-9.
2008: Kristel Peeters; Jean Marie Stassen; Désiré Collen; Chris Van Geet; Kathleen Freson
Emerging treatments for thrombocytopenia: increasing platelet production.
Drug discovery today 2008;13(17-18):798-806.
2008: Kathleen Freson; Karen Peeters; Rita De Vos; Christine Wittevrongel; Chantal Thys; Marc F Hoylaerts; Jos Vermylen; Chris Van Geet
PACAP and its receptor VPAC1 regulate megakaryocyte maturation: therapeutic implications.
Blood 2008;111(4):1885-93.
2008: Veerle Labarque; Kathleen Freson; Chantal Thys; Christine Wittevrongel; Marc F Hoylaerts; Rita De Vos; Nathalie Goemans; Chris Van Geet
Increased Gs signalling in platelets and impaired collagen activation, due to a defect in the dystrophin gene, result in increased blood loss during spinal surgery.
Human molecular genetics 2008;17(3):357-66.
2007: Kathleen Freson; Katarzyna Stolarz; Raymond Aerts; Eva Brand; Stefan-Martin Brand-Herrmann; Kalina Kawecka-Jaszcz; Tatiana Kuznetsova; Valérie Tikhonoff; Lutgarde Thijs; Jos Vermylen; Jan A Staessen; Chris Van Geet
-391 C to G substitution in the regulator of G-protein signalling-2 promoter increases susceptibility to the metabolic syndrome in white European men: consistency between molecular and epidemiological studies.
Journal of hypertension 2007;25(1):117-25.
2007: Katja De Munnynck; Chris Van Geet; R De Vos; Wim Van de Voorde
delta-Storage pool disease: a pitfall in the forensic investigation of sudden anal blood loss in children: a case report.
International journal of legal medicine 2007;121(1):44-7.
2006: Kathleen Freson; Chantal Thys; Christine Wittevrongel; Chris Van Geet
Mechanisms of action and targets for actual and future antiplatelet drugs.
Mini reviews in medicinal chemistry 2006;6(6):719-26.
2006: Karen Deraedt; Vincent Vander Poorten; Chris Van Geet; Marleen Renard; Ivo De Wever; Raf Sciot
Multifocal kaposiform haemangioendothelioma.
Virchows Archiv : an international journal of pathology 2006;448(6):843-6.
2005: Kathleen Freson; Rita De Vos; Christine Wittevrongel; Chantal Thys; Johan Defoor; Luc Vanhees; Jos Vermylen; Kathelijne Peerlinck; Chris Van Geet
The TUBB1 Q43P functional polymorphism reduces the risk of cardiovascular disease in men by modulating platelet function and structure.
Blood 2005;106(7):2356-62.
2005: Béatrice Gulbis; David Haberman; Dominique Dufour; Catherine Christophe; Christiane Vermylen; Faustin Kagambega; Francis Corazza; Christine Devalck; Marie-Françoise Dresse; Kathleen Hunninck; Axel Klein; Phu Quoc Le; Michèle Loop; Philip Maes; Pierre Philippet; Eric Sariban; Chris Van Geet; Alina Ferster
Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience.
Blood 2005;105(7):2685-90.
2005: Willem Proesmans; Patricia van de Wijdeven; Chris Van Geet
Thrombophilia in neonatal renal venous and arterial thrombosis.
Pediatric nephrology (Berlin, Germany) 2005;20(2):241-2.
2004: Kristina Casteels; Carine Wouters; Chris Van Geet; Hugo Devlieger
Video reveals self-stimulation in infancy.
Acta paediatrica (Oslo, Norway : 1992) 2004;93(6):844-6.
2004: Kathleen Freson; Hitoshi Hashimoto; Chantal Thys; Christine Wittevrongel; Sophie Danloy; Yoshiko Morita; Norihito Shintani; Yoshiaki Tomiyama; Jos Vermylen; Marc F Hoylaerts; Akemichi Baba; Chris Van Geet
The pituitary adenylate cyclase-activating polypeptide is a physiological inhibitor of platelet activation.
The Journal of clinical investigation 2004;113(6):905-12.
2004: Chris Van Geet
Thrombopoiesis: new concepts.
Verhandelingen - Koninklijke Academie voor Geneeskunde van België 2004;66(1):5-24; discussion 24-7.
2003: J B Ruige; Chris Van Geet; André Nevelsteen; Raymond Verhaeghe
A 16-year survey of Takayasu's arteritis in a tertiary Belgian center.
International angiology : a journal of the International Union of Angiology 2003;22(4):414-20.
2003: Kathleen Freson; Jaak Jaeken; Monique Van Helvoirt; Francis de Zegher; Christine Wittevrongel; Chantal Thys; Marc F Hoylaerts; Jos Vermylen; Chris Van Geet
Functional polymorphisms in the paternally expressed XLalphas and its cofactor ALEX decrease their mutual interaction and enhance receptor-mediated cAMP formation.
Human molecular genetics 2003;12(10):1121-30.
2003: Kristina Casteels; Dominique Beckers; Carine Wouters; Chris Van Geet
Rhabdomyolysis in diabetic ketoacidosis.
Pediatric diabetes 2003;4(1):29-31.
2003: Kathleen Freson; Chantal Thys; Christine Wittewrongel; Jos Vermylen; Marc F Hoylaerts; Chris Van Geet
Molecular cloning and characterization of the GATA1 cofactor human FOG1 and assessment of its binding to GATA1 proteins carrying D218 substitutions.
Human genetics 2003;112(1):42-9.
2002: Kathleen Freson; Chantal Thys; Christine Wittevrongel; Willem Proesmans; Marc F Hoylaerts; Jos Vermylen; Chris Van Geet
Pseudohypoparathyroidism type Ib with disturbed imprinting in the GNAS1 cluster and Gsalpha deficiency in platelets.
Human molecular genetics 2002;11(22):2741-50.
2002: Willem Proesmans; An D'Hooge; Maria Van Dyck; Chris Van Geet
thrombophilia in childhood hemolytic uremic syndrome.
Pediatric nephrology (Berlin, Germany) 2002;17(8):699-700.
2002: M Casteels-Van Daele; Carine Wouters; Chris Van Geet; M C McGovern; J F T Glasgow; MC Stewart
Reye's syndrome revisited. Outdated concept of Reye's syndrome was used.
BMJ (Clinical research ed.) 2002;324(7336):546.
2002: Kathleen Freson; Gert Matthijs; Chantal Thys; Paul Mariën; Marc F Hoylaerts; Jos Vermylen; Chris Van Geet
Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation.
Human molecular genetics 2002;11(2):147-52.
2001: Kathleen Freson; Marc F Hoylaerts; Jaak Jaeken; M Eyssen; Jef Arnout; Jos Vermylen; Chris Van Geet
Genetic variation of the extra-large stimulatory G protein alpha-subunit leads to Gs hyperfunction in platelets and is a risk factor for bleeding.
Thrombosis and haemostasis 2001;86(3):733-8.
2001: Chris Van Geet; Jaak Jaeken; Kathleen Freson; T Lenaerts; Jef Arnout; Jos Vermylen; Marc F Hoylaerts
Congenital disorders of glycosylation type Ia and IIa are associated with different primary haemostatic complications.
Journal of inherited metabolic disease 2001;24(4):477-92.
2001: M Casteels-Van Daele; Chris Van Geet; Carine Wouters; E Eggermont
Reye's syndrome.
Lancet 2001;358(9278):334.
2001: Kathleen Freson; koenraad devriendt; Gert Matthijs; Achiel Van Hoof; Rita De Vos; Chantal Thys; K Minner; Marc F Hoylaerts; Jos Vermylen; Chris Van Geet
Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation.
Blood 2001;98(1):85-92.
2001: Alina Ferster; P Tahriri; Christiane Vermylen; G Sturbois; Francis Corazza; Pierre Fondu; Christine Devalck; Marie-Françoise Dresse; W Feremans; Kathleen Hunninck; Michèle Toppet; Pierre Philippet; Chris Van Geet; Eric Sariban
Five years of experience with hydroxyurea in children and young adults with sickle cell disease.
Blood 2001;97(11):3628-32.
2000: Rolf Ljung; S Aronis-Vournas; K Kurnik-Auberger; M van den Berg; Hervé Chambost; Ségolène Claeyssens; Chris Van Geet; A Glomstein; Ian Hann; F Hill; R Kobelt; Wolfhart Kreuz; G Mancuso; W Muntean; P Petrini; L Rosado; Elma Scheibel; M Siimes; O Smith; J Tusell
Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries.
Haemophilia : the official journal of the World Federation of Hemophilia 2000;6(6):619-24.
2000: M Casteels-Van Daele; Chris Van Geet; Carine Wouters; E Eggermont
Reye syndrome revisited: a descriptive term covering a group of heterogeneous disorders.
European journal of pediatrics 2000;159(9):641-8.
2000: Cécile Oury; Emese Toth-Zsamboki; Chris Van Geet; Chantal Thys; L Wei; Bernd Nilius; Jos Vermylen; Marc F Hoylaerts
A natural dominant negative P2X1 receptor due to deletion of a single amino acid residue.
The Journal of biological chemistry 2000;275(30):22611-4.
1998: Chris Van Geet; koenraad devriendt; Benedicte Eyskens; Jos Vermylen; Marc F Hoylaerts
Velocardiofacial syndrome patients with a heterozygous chromosome 22q11 deletion have giant platelets.
Pediatric research 1998;44(4):607-11.
1998: Chris Van Geet; Willem Proesmans; Jef Arnout; J Vermylen; P J Declerck
Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Kidney international 1998;54(4):1324-30.
1998: Kristina Casteels; Chris Van Geet; K Wouters
Ethosuximide-associated lupus with cerebral and renal manifestations.
European journal of pediatrics 1998;157(9):780.
1998: Jos Vermylen; Chris Van Geet; Jef Arnout
Antibody-mediated thrombosis: relation to the antiphospholipid syndrome.
Lupus 1998;7 Suppl 2():S63-6.
1997: P Moerman; Chris Van Geet; H Devlieger
Lymphangiomatosis of the body wall: a report of two cases associated with chylothorax and fatal outcome.
Pediatric pathology & laboratory medicine : journal of the Society for Pediatric Pathology, affiliated with the International Paediatric Pathology Association 1997;17(4):617-24.
1997: koenraad devriendt; Gert Matthijs; Eric Legius; Els Schollen; Daniel Blockmans; Chris Van Geet; H Degreef; Jean-Jacques Cassiman; Jean-Pierre Fryns
Skewed X-chromosome inactivation in female carriers of dyskeratosis congenita.
American journal of human genetics 1997;60(3):581-7.
1997: M Casteels-Van Daele; Chris Van Geet; K Wouters; E Eggermont
The changing clinical pattern of Reye's syndrome 1982-90.
Archives of disease in childhood 1997;76(1):79.
1996: I Van Biljon; Rita Van Damme-Lombaerts; A Demol; Chris Van Geet; Willem Proesmans; J Arnout
Low molecular weight heparin for anticoagulation during haemodialysis in children--a preliminary study.
European journal of pediatrics 1996;155(1):70.
1995: M Carrette; P Brock; Anne Uyttebroeck; Chris Van Geet; K Segers; M Casteels-Van Daele
[Transient erythroblastopenia in 4 children].
Nederlands tijdschrift voor geneeskunde 1995;139(46):2375-7.
1994: Chris Van Geet; Maria Van Dyck; Willem Proesmans
Subcutaneous recombinant erythropoietin in preterminal renal insufficiency.
European journal of pediatrics 1994;153(2):129-32.
1993: Chris Van Geet; Jaak Jaeken
A unique pattern of coagulation abnormalities in carbohydrate-deficient glycoprotein syndrome.
Pediatric research 1993;33(5):540-1.
1993: F André Van Assche; Bernard Spitz; Myriam Hanssens; Chris Van Geet; Jef Arnout; Jos Vermylen
Increased thromboxane formation in diabetic pregnancy as a possible contributor to preeclampsia.
American journal of obstetrics and gynecology 1993;168(1 Pt 1):84-7.
1993: Jaak Jaeken; P De Cock; H Stibler; Chris Van Geet; J Kint; Vincent T Ramaekers; Hubert A Carchon
Carbohydrate-deficient glycoprotein syndrome type II.
Journal of inherited metabolic disease 1993;16(6):1041.
1991: Chris Van Geet; L Vandenbossche; E Eggermont; Hugo Devlieger; Jos Vermylen; Jaak Jaeken
Possible platelet contribution to pathogenesis of transient neonatal hyperammonaemia syndrome.
Lancet 1991;337(8733):73-5.
1990: Chris Van Geet; Rita Van Damme-Lombaerts; M Vanrusselt; A de Mol; Willem Proesmans; Jos Vermylen
Recombinant human erythropoietin increases blood pressure, platelet aggregability and platelet free calcium mobilisation in uraemic children: a possible link?
Thrombosis and haemostasis 1990;64(1):7-10.
1990: Bernard Hoet; Jef Arnout; Chris Van Geet; Hans Deckmyn; Raymond Verhaeghe; Jos Vermylen
Ridogrel, a combined thromboxane synthase inhibitor and receptor blocker, decreases elevated plasma beta-thromboglobulin levels in patients with documented peripheral arterial disease.
Thrombosis and haemostasis 1990;64(1):87-90.
1990: Chris Van Geet; Hans Deckmyn; Joachim Kienast; Christine Wittevrongel; Jos Vermylen
Guanine nucleotide-dependent inhibition of phospholipase C in human endothelial cells.
The Journal of biological chemistry 1990;265(14):7920-6.
1990: Chris Van Geet; Jef Arnout; E Eggermont; Jos Vermylen
Urinary thromboxane B2 and 2,3-dinor-thromboxane B2 in the neonate born at full-term age.
Eicosanoids 1990;3(1):39-43.
1989: Chris Van Geet; D Hauglustaine; L Verresen; M Vanrusselt; Jos Vermylen
Haemostatic effects of recombinant human erythropoietin in chronic haemodialysis patients.
Thrombosis and haemostasis 1989;61(1):117-21.
1989: Chris Van Geet; Hans Deckmyn; Joachim Kienast; Christine Wittevrongel; Jos Vermylen
Dual effect of fluoride on endothelial prostacyclin production: a phospholipase C mediated phenomenon.
Progress in clinical and biological research 1989;301():377-81.